FMR LLC 13D and 13G filings for Bicara Therapeutics Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-05 1:16 pm Purchase | 2025-12-31 | 13G | BICARA THERAPEUTICS INC BCAX | FMR LLC | 3,347,223 6.100% | 591,006 (+21.44%) | Filing |
| 2025-07-17 11:11 am Purchase | 2025-07-10 | 13G | BICARA THERAPEUTICS INC BCAX | FMR LLC | 2,756,217 5.100% | 217,813 (+8.58%) | Filing |
| 2025-07-17 11:08 am Sale | 2025-06-30 | 13G | BICARA THERAPEUTICS INC BCAX | FMR LLC | 2,538,404 4.700% | -1,073,169 (-29.71%) | Filing |
| 2025-05-12 10:28 am Purchase | 2025-03-31 | 13G | BICARA THERAPEUTICS INC BCAX | FMR LLC | 3,611,573 6.600% | 807,766 (+28.81%) | Filing |
| 2025-03-03 09:14 am Purchase | 2025-02-24 | 13G | BICARA THERAPEUTICS INC BCAX | FMR LLC | 2,803,807 5.200% | 686,719 (+32.44%) | Filing |
| 2025-02-12 09:16 am Sale | 2024-12-31 | 13G | BICARA THERAPEUTICS INC BCAX | FMR LLC | 2,117,088 3.900% | -378,245 (-15.16%) | Filing |
| 2024-09-18 11:57 am Purchase | 2024-09-18 | 13G | BICARA THERAPEUTICS INC BCAX | FMR LLC | 2,495,333 5.095% | 2,495,333 (New Position) | Filing |